English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Trending
+
Regulatory
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
+
Regulatory
Patient Daily
| Apr 29, 2026
USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
+
Regulatory
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
No Results
